Mirroring genetic studies, small-molecule RIPK1 inhibitor GNE684 therapy in Sharpincpdm/cpdm mice with established dermatitis reduced inflammation and caspase-3 cleavage in the skin [135,152]. This evidence concerns the gene RIPK1 and dermatitis.